Molecular Detection of Multiple Antimicrobial Resistance Genes in Helicobacter pylori-Positive Gastric Samples from Patients Undergoing Upper Gastrointestinal Endoscopy with Gastric Biopsy in Algarve, Portugal
Abstract
1. Introduction
2. Results
2.1. Detection of Genes Conferring Resistance to Antimicrobials
2.2. Sequencing and Sequence Analysis of Positive PCR Products
3. Discussion
4. Materials and Methods
4.1. Sample Collection
4.2. Molecular Analysis
4.3. Statistical Analysis
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Sun, Q.; Yuan, C.; Zhou, S.; Lu, J.; Zeng, M.; Cai, X.; Song, H. Helicobacter pylori infection: A dynamic process from diagnosis to treatment. Front. Cell. Infect. Microbiol. 2023, 13, 1257817. [Google Scholar] [CrossRef]
- Malfertheiner, P.; Camargo, M.C.; El-Omar, E.; Liou, J.M.; Peek, R.; Schulz, C.; Smith, S.I.; Suerbaum, S. Helicobacter pylori infection. Nat. Rev. Dis. Primers 2023, 9, 19. [Google Scholar] [CrossRef] [PubMed]
- Li, Y.; Choi, H.; Leung, K.; Jiang, F.; Graham, D.Y.; Leung, W.K. Global prevalence of Helicobacter pylori infection between 1980 and 2022: A systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 2023, 8, 553–564. [Google Scholar] [CrossRef] [PubMed]
- Matos, R.; Taillieu, E.; De Bruyckere, S.; De Witte, C.; Rêma, A.; Santos-Sousa, H.; Nogueiro, J.; Reis, C.A.; Carneiro, F.; Haesebrouck, F.; et al. Presence of Helicobacter Species in Gastric Mucosa of Human Patients and Outcome of Helicobacter Eradication Treatment. J. Pers. Med. 2022, 12, 181. [Google Scholar] [CrossRef]
- Zamani, M.; Ebrahimtabar, F.; Zamani, V.; Miller, W.H.; Alizadeh-Navaei, R.; Shokri-Shirvani, J.; Derakhshan, M.H. Systematic review with meta-analysis: The worldwide prevalence of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 2018, 47, 868–876. [Google Scholar] [CrossRef]
- Bastos, J.; Peleteiro, B.; Barros, R.; Alves, L.; Severo, M.; de Fátima Pina, M.; Pinto, H.; Carvalho, S.; Marinho, A.; Guimarães, J.T.; et al. Sociodemographic determinants of prevalence and incidence of Helicobacter pylori infection in Portuguese adults. Helicobacter 2013, 18, 413–422. [Google Scholar] [CrossRef]
- Cortez Nunes, F.; Mateus, T.L.; Aguieiras, C.; Louro, R.; Peixe, B.; Calhindro, M.; Queirós, P.; Castelo-Branco, P. Prevalence and Diagnostic Comparison of Helicobacter pylori and Non-Helicobacter pylori Helicobacter Infections in Patients Undergoing Upper Gastrointestinal Endoscopy with Gastric Biopsy in Algarve, Portugal. Microorganisms 2025, 13, 1684. [Google Scholar] [CrossRef]
- Bujanda, L.; Nyssen, O.P.; Vaira, D.; Saracino, I.M.; Fiorini, G.; Lerang, F.; Georgopoulos, S.; Tepes, B.; Heluwaert, F.; Gasbarrini, A.; et al. Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013–2020: Results of the European Registry on H. pylori Management (Hp-EuReg). Antibiotics 2021, 10, 1058. [Google Scholar] [CrossRef]
- Megraud, F.; Bruyndonckx, R.; Coenen, S.; Wittkop, L.; Huang, T.D.; Hoebeke, M.; Bénéjat, L.; Lehours, P.; Goossens, H.; Glupczynski, Y. Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community. Gut 2021, 70, 1815–1822. [Google Scholar] [CrossRef] [PubMed]
- Savoldi, A.; Carrara, E.; Graham, D.Y.; Conti, M.; Tacconelli, E. Prevalence of Antibiotic Resistance in Helicobacter pylori; Systematic Review and Meta-analysis in World Health Organization Regions. Gastroenterology 2018, 155, 1372–1382.e1317. [Google Scholar] [CrossRef]
- García-Morales, N.; Pérez-Aísa, Á.; Fiorini, G.; Tepes, B.; Castro-Fernández, M.; Lucendo, A.; Voynovan, I.; Bujanda, L.; Garre, A.; Rodrigo, L.; et al. Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management. J. Clin. Med. 2023, 12, 4363. [Google Scholar] [CrossRef]
- Viegas, M.I.; Areia, M.; Elvas, L.; Marcos-Pinto, R.; Fernandes-Mendes, H.; Alves, S.; Brito, D.; Saraiva, S.; Cadime, A.T.; Cano-Català, A.; et al. Effectiveness of First-Line Empirical Treatment in Portugal: Data from the European Registry on Helicobacter pylori Management. GE—Port. J. Gastroenterol. 2024. [Google Scholar] [CrossRef]
- Lopo, I.; Libânio, D.; Pita, I.; Dinis-Ribeiro, M.; Pimentel-Nunes, P. Helicobacter pylori antibiotic resistance in Portugal: Systematic review and meta-analysis. Helicobacter 2018, 23, e12493. [Google Scholar] [CrossRef]
- Almeida, N.; Romãozinho, J.M.; Donato, M.M.; Luxo, C.; Cardoso, O.; Cipriano, M.A.; Marinho, C.; Fernandes, A.; Calhau, C.; Sofia, C. Helicobacter pylori antimicrobial resistance rates in the central region of Portugal. Clin. Microbiol. Infect. 2014, 20, 1127–1133. [Google Scholar] [CrossRef] [PubMed]
- Malfertheiner, P.; Megraud, F.; Rokkas, T.; Gisbert, J.P.; Liou, J.M.; Schulz, C.; Gasbarrini, A.; Hunt, R.H.; Leja, M.; O’Morain, C.; et al. Management of Helicobacter pylori infection: The Maastricht VI/Florence consensus report. Gut 2022, 71, 1724–1762. [Google Scholar] [CrossRef] [PubMed]
- Alfaro, E.; Sostres, C.; Lanas, A. Diagnosis and Treatment of Helicobacter pylori Infection in Real Practice-New Role of Primary Care Services in Antibiotic Resistance Era. Diagnostics 2023, 13, 1918. [Google Scholar] [CrossRef] [PubMed]
- Lin, Y.; Shao, Y.; Yan, J.; Ye, G. Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practice. J. Clin. Lab. Anal. 2023, 37, e24885. [Google Scholar] [CrossRef]
- WHO, Criticaly Important Antimicrobials for Human Medicine. Available online: https://apps.who.int/iris/bitstream/handle/10665/312266/9789241515528-eng.pdf (accessed on 3 May 2025).
- Dang, B.N.; Graham, D.Y. Helicobacter pylori infection and antibiotic resistance: A WHO high priority? Nat. Rev. Gastroenterol. Hepatol. 2017, 14, 383–384. [Google Scholar] [CrossRef]
- Katelaris, P.; Hunt, R.; Bazzoli, F.; Cohen, H.; Fock, K.M.; Gemilyan, M.; Malfertheiner, P.; Mégraud, F.; Piscoya, A.; Quach, D.; et al. Helicobacter pylori World Gastroenterology Organization Global Guideline. J. Clin. Gastroenterol. 2023, 57, 111–126. [Google Scholar] [CrossRef]
- Jung, H.K.; Kang, S.J.; Lee, Y.C.; Yang, H.J.; Park, S.Y.; Shin, C.M.; Kim, S.E.; Lim, H.C.; Kim, J.H.; Nam, S.Y.; et al. Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea 2020. Gut Liver 2021, 15, 168–195. [Google Scholar] [CrossRef]
- Malfertheiner, P.; Megraud, F.; O’Morain, C.A.; Gisbert, J.P.; Kuipers, E.J.; Axon, A.T.; Bazzoli, F.; Gasbarrini, A.; Atherton, J.; Graham, D.Y.; et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut 2017, 66, 6–30. [Google Scholar] [CrossRef] [PubMed]
- Taillieu, E.; De Witte, C.; De Schepper, H.; Van Moerkercke, W.; Rutten, S.; Michiels, S.; Arnst, Y.; De Bruyckere, S.; Francque, S.; van Aert, F.; et al. Clinical significance and impact of gastric non-Helicobacter pylori Helicobacter species in gastric disease. Aliment. Pharmacol. Ther. 2023, 57, 1432–1444. [Google Scholar] [CrossRef] [PubMed]
- Nista, E.C.; Pellegrino, A.; Giuli, L.; Candelli, M.; Schepis, T.; De Lucia, S.S.; Ojetti, V.; Franceschi, F.; Gasbarrini, A. Clinical Implications of Helicobacter pylori Antibiotic Resistance in Italy: A Review of the Literature. Antibiotics 2022, 11, 1452. [Google Scholar] [CrossRef]
- Tshibangu-Kabamba, E.; Yamaoka, Y. Helicobacter pylori infection and antibiotic resistance—from biology to clinical implications. Nat. Rev. Gastroenterol. Hepatol. 2021, 18, 613–629. [Google Scholar] [CrossRef]
- Lee, S.M.; Kim, N.; Kwon, Y.H.; Nam, R.H.; Kim, J.M.; Park, J.Y.; Lee, Y.S.; Lee, D.H. rdxA, frxA, and efflux pump in metronidazole-resistant Helicobacter pylori: Their relation to clinical outcomes. J. Gastroenterol. Hepatol. 2018, 33, 681–688. [Google Scholar] [CrossRef]
- Salahi-Niri, A.; Nabavi-Rad, A.; Monaghan, T.M.; Rokkas, T.; Doulberis, M.; Sadeghi, A.; Zali, M.R.; Yamaoka, Y.; Tacconelli, E.; Yadegar, A. Global prevalence of Helicobacter pylori antibiotic resistance among children in the world health organization regions between 2000 and 2023: A systematic review and meta-analysis. BMC Med. 2024, 22, 598. [Google Scholar] [CrossRef]
- Almashhadany, D.A.; Mayas, S.M.; Mohammed, H.I.; Hassan, A.A.; Khan, I.U.H. Population- and Gender-Based Investigation for Prevalence of Helicobacter pylori in Dhamar, Yemen. Can. J. Gastroenterol. Hepatol. 2023, 2023, 3800810. [Google Scholar] [CrossRef]
- White, B.; Winte, M.; DeSipio, J.; Phadtare, S. Clinical Factors Implicated in Antibiotic Resistance in Helicobacter pylori Patients. Microorganisms 2022, 10, 322. [Google Scholar] [CrossRef]
- Cortez Nunes, F.; Taillieu, E.; Letra Mateus, T.; Teixeira, S.; Haesebrouck, F.; Amorim, I. Molecular Detection of Metronidazole and Tetracycline Resistance Genes in Helicobacter pylori-Like Positive Gastric Samples from Pigs. Antibiotics 2023, 12, 906. [Google Scholar] [CrossRef]
- Alcock, B.P.; Huynh, W.; Chalil, R.; Smith, K.W.; Raphenya, A.R.; Wlodarski, M.A.; Edalatmand, A.; Petkau, A.; Syed, S.A.; Tsang, K.K.; et al. CARD 2023: Expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database. Nucleic Acids Res. 2023, 51, D690–D699. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Zheng, S.; Guo, R.; Li, Y.; Yin, H.; Qiu, X.; Chen, J.; Ni, C.; Yuan, Y.; Gong, Y. Assessment for antibiotic resistance in Helicobacter pylori: A practical and interpretable machine learning model based on genome-wide genetic variation. Virulence 2025, 16, 2481503. [Google Scholar] [CrossRef] [PubMed]
- Hashemi, S.J.; Sheikh, A.F.; Goodarzi, H.; Yadyad, M.J.; Seyedian, S.S.; Aslani, S.; Assarzadegan, M.A. Genetic basis for metronidazole and clarithromycin resistance in Helicobacter pylori strains isolated from patients with gastroduodenal disorders. Infect. Drug Resist. 2019, 12, 535–543. [Google Scholar] [CrossRef]
- Marques, B.; Donato, M.M.; Cardoso, O.; Luxo, C.; Martinho, A.; Almeida, N. Study of rdxA and frxA genes mutations in metronidazole-resistant and -susceptible Helicobacter pylori clinical isolates from the central region of Portugal. J. Glob. Antimicrob. Resist. 2019, 17, 300–304. [Google Scholar] [CrossRef]
- Kasahun, G.G.; Demoz, G.T.; Desta, D.M. Primary Resistance Pattern of Helicobacter pylori to Antibiotics in Adult Population: A Systematic Review. Infect. Drug Resist. 2020, 13, 1567–1573. [Google Scholar] [CrossRef]
- Zhang, Y.; Meng, F.; Jin, J.; Wang, J.; Gu, B.B.; Peng, J.B.; Ye, L.P. Ninety-four thousand-case retrospective study on antibacterial drug resistance of Helicobacter pylori. World J. Clin. Cases 2021, 9, 10838–10849. [Google Scholar] [CrossRef]
- González-Hormazábal, P.; Arenas, A.; Serrano, C.; Pizarro, M.; Fuentes-López, E.; Arnold, J.; Berger, Z.; Musleh, M.; Valladares, H.; Lanzarini, E.; et al. Prevalence of Helicobacter pylori Antimicrobial Resistance Among Chilean Patients. Arch. Med. Res. 2021, 52, 529–534. [Google Scholar] [CrossRef]
- Deepshikha, B.; Srishti, G.; Esmita, C. Understanding gender inequities in antimicrobial resistance: Role of biology, behaviour and gender norms. BMJ Glob. Health 2025, 10, e016711. [Google Scholar] [CrossRef]
- Wong, C. Drug-resistant infections more likely to strike women, says WHO. Nature 2024. [Google Scholar] [CrossRef] [PubMed]
- Waterlow, N.R.; Cooper, B.S.; Robotham, J.V.; Knight, G.M. Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational study. PLoS Med. 2024, 21, e1004301. [Google Scholar] [CrossRef] [PubMed]
- Tanashat, M.; Abuelazm, M.; Abouzid, M.; Al-Ajlouni, Y.A.; Ramadan, A.; Alsalah, S.; Sharaf, A.; Ayman, D.; Elharti, H.; Zhana, S.; et al. Efficacy of probiotics regimens for Helicobacter pylori eradication: A systematic review, pairwise, and network meta-analysis of randomized controlled trials. Clin. Nutr. ESPEN 2025, 65, 424–444. [Google Scholar] [CrossRef]
- Diab, M.; El-Shenawy, A.; El-Ghannam, M.; Salem, D.; Abdelnasser, M.; Shaheen, M.; Abdel-Hady, M.; El-Sherbini, E.; Saber, M. Detection of antimicrobial resistance genes of Helicobacter pylori strains to clarithromycin, metronidazole, amoxicillin and tetracycline among Egyptian patients. Egypt. J. Med. Hum. Genet. 2018, 19, 417–423. [Google Scholar] [CrossRef]
- Stecher, G.; Tamura, K.; Kumar, S. Molecular Evolutionary Genetics Analysis (MEGA) for macOS. Mol. Biol. Evol. 2020, 37, 1237–1239. [Google Scholar] [CrossRef] [PubMed]
- Altschul, S.F.; Gish, W.; Miller, W.; Myers, E.W.; Lipman, D.J. Basic local alignment search tool. J. Mol. Biol. 1990, 215, 403–410. [Google Scholar] [CrossRef]
- Benson, D.A.; Karsch-Mizrachi, I.; Lipman, D.J.; Ostell, J.; Rapp, B.A.; Wheeler, D.L. GenBank. Nucleic Acids Res. 2002, 30, 17–20. [Google Scholar] [CrossRef] [PubMed]
Total | Male | Female | ||
---|---|---|---|---|
N | 18 | 7 | 11 | |
n (%) | n (%) | n (%) | ||
ARG positive | 16 (88.9%) | 5 (71.4%) | 11 (100%) | |
Amoxicillin Pbp1A gene | 5 (27.8%) | 1 (14.3%) | 4 (36.4%) | |
Clarithromycin 23s rRNA gene | 3 (16.7%) | 2 (28.6%) | 1 (9.1%) | |
Metronidazole rdxA gene | 15 (83.3%) | 4 (57.1%) | 11 (100%) | p = 0.043 |
Metronidazole frxA gene | 12 (66.7%) | 4 (57.1%) | 8 (72.7%) | |
Tetracycline 16s rRNA mutation gene | 12 (66.7%) | 4 (57.1%) | 8 (72.7%) |
Resistance Patterns | n (%) |
---|---|
No resistance | 2 (11.1%) |
Mono resistance | |
Metronidazole | 2 (11.1%) |
Tetracycline | 1 (5.6%) |
Dual resistance | |
Amoxicillin + Metronidazole | 2 (11.1%) |
Metronidazole + Tetracycline | 6 (33.3%) |
Triple resistance | |
Amoxicillin + Metronidazole + Tetracycline | 2 (11.1%) |
Metronidazole + Tetracycline + Clarithromycin | 2 (11.1%) |
Quadruple resistance | |
Amoxicillin + Metronidazole + Tetracycline + Clarithromycin | 1 (5.6%) |
Antimicrobials | Sequence | Target Gene | Thermo Cycle Conditions | Reference | |||
---|---|---|---|---|---|---|---|
Temp. (°C) | Time | Nr. Cycles | |||||
Amoxicillin | Forward | GCG ACA ATA AGA GTG GCA | Pbp1A | 95 95 56 72 72 | 3′ 1′ 1′ 5′ 10′ | 35 | [26,30,42] |
Reverse | TGC GAA CAC CCT TTT AAA T | ||||||
Metronidazole | Forward | AAT TTG AGC ATG GGG CAG A | rdxA | 95 94 60 72 72 | 5′ 30″ 30″ 1′ 10′ | 35 | [26,30,42] |
Reverse | GAA ACG CTT GAA AAC ACC CCT | ||||||
Forward | TGG ATA TGG CAG CCG TTT A | frxA | 95 95 58 72 72 | 5′ 30″ 30″ 1′ 10′ | 35 | [26,30,42] | |
Reverse | GGT TAT CAA AAA GCT AAC AGC G | ||||||
Tetracycline | Forward | CGG TCG CAA GAT TAA AAC | 16S rRNA mutation | 95 95 55 72 72 | 10′ 5″ 2″ 30″ 10′ | 45 | [30,42] |
Reverse | GCG GAT TCT CTC AAT GTC | ||||||
Clarithromycin | Forward | TCA GTG AAA TTG TAG TGG AGG TGA AAA | 23S rRNA | 95 92 60 72 72 | 10′ 15″ 1′ 1′ 10′ | 40 | [30,42] |
Reverse | CAG TGC TAA GTT GTA GTA AAG GTC CA |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cortez Nunes, F.; Aguieiras, C.; Calhindro, M.; Louro, R.; Peixe, B.; Queirós, P.; Castelo-Branco, P.; Mateus, T.L. Molecular Detection of Multiple Antimicrobial Resistance Genes in Helicobacter pylori-Positive Gastric Samples from Patients Undergoing Upper Gastrointestinal Endoscopy with Gastric Biopsy in Algarve, Portugal. Antibiotics 2025, 14, 780. https://doi.org/10.3390/antibiotics14080780
Cortez Nunes F, Aguieiras C, Calhindro M, Louro R, Peixe B, Queirós P, Castelo-Branco P, Mateus TL. Molecular Detection of Multiple Antimicrobial Resistance Genes in Helicobacter pylori-Positive Gastric Samples from Patients Undergoing Upper Gastrointestinal Endoscopy with Gastric Biopsy in Algarve, Portugal. Antibiotics. 2025; 14(8):780. https://doi.org/10.3390/antibiotics14080780
Chicago/Turabian StyleCortez Nunes, Francisco, Catarina Aguieiras, Mauro Calhindro, Ricardo Louro, Bruno Peixe, Patrícia Queirós, Pedro Castelo-Branco, and Teresa Letra Mateus. 2025. "Molecular Detection of Multiple Antimicrobial Resistance Genes in Helicobacter pylori-Positive Gastric Samples from Patients Undergoing Upper Gastrointestinal Endoscopy with Gastric Biopsy in Algarve, Portugal" Antibiotics 14, no. 8: 780. https://doi.org/10.3390/antibiotics14080780
APA StyleCortez Nunes, F., Aguieiras, C., Calhindro, M., Louro, R., Peixe, B., Queirós, P., Castelo-Branco, P., & Mateus, T. L. (2025). Molecular Detection of Multiple Antimicrobial Resistance Genes in Helicobacter pylori-Positive Gastric Samples from Patients Undergoing Upper Gastrointestinal Endoscopy with Gastric Biopsy in Algarve, Portugal. Antibiotics, 14(8), 780. https://doi.org/10.3390/antibiotics14080780